Visit us at our booth on 25th June 2022
at 10th Frankfurt Symposium on Endocrine Surgery at the German National Library Frankfurt on the Main, Germany.
We introduce our new gentle and organ-preserving ThyLA DUAL laser therapy for benign thyroid nodules. Learn about significant reduction of nodule volumes after laser thermoablation treatment in study by Li, ZhiXian et al published June 2020 in Lasers in Surgery and Medicine (click HERE).
Welcome to biolitec®‘s trendsetting laser systems for minimally invasive organ- and as well function-preserving treatment of benign thyroid noduls.
During the laser thermal ablation, similar to a biopsy with ultrasound monitoring, the special ThyLA fiber is introduced into the thyroid nodule to coagulate the nodular tissue through selective radiation. The method is the so-called “multiple overlapping shot technique” (moving shot technique) ‒ to enable a homogeneous and controlled penetration depth and, at the same time, an excellent ultrasound view: The ThyLA fiber is replaced intranodally after each pulse. Thus multiple coagulative necroses are placed, and the entire nodule is treated.
For more information about where to find us at upcoming Endocrinology fairs, please click HERE.
- High effectiveness, reduction of the nodule volume by about 50 % after three months
- Outpatient treatment
- Protection and preservation of healthy thyroid tissue
- Good cosmetic results
- Easy to control penetration depth
- Treatment can be repeated as needed
- Suitable for risk patients